Results
|
1541.
|
Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases. [electronic resource] by
- Sini, Patrizia
- Gürtler, Ulrich
- Zahn, Stephan K
- Baumann, Christoph
- Rudolph, Dorothea
- Baumgartinger, Rosa
- Strauss, Eva
- Haslinger, Christian
- Tontsch-Grunt, Ulrike
- Waizenegger, Irene C
- Solca, Flavio
- Bader, Gerd
- Zoephel, Andreas
- Treu, Matthias
- Reiser, Ulrich
- Garin-Chesa, Pilar
- Boehmelt, Guido
- Kraut, Norbert
- Quant, Jens
- Adolf, Günther R
Producer: 20170615
In:
Molecular cancer therapeutics vol. 15
Availability: No items available.
|
|
1542.
|
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line. [electronic resource] by
- Pezzani, Raffaele
- Rubin, Beatrice
- Bertazza, Loris
- Redaelli, Marco
- Barollo, Susi
- Monticelli, Halenya
- Baldini, Enke
- Mian, Caterina
- Mucignat, Carla
- Scaroni, Carla
- Mantero, Franco
- Ulisse, Salvatore
- Iacobone, Maurizio
- Boscaro, Marco
Producer: 20171214
In:
Investigational new drugs vol. 34
Availability: No items available.
|
|
1543.
|
|
|
1544.
|
The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. [electronic resource] by
- Hauf, Silke
- Cole, Richard W
- LaTerra, Sabrina
- Zimmer, Christine
- Schnapp, Gisela
- Walter, Rainer
- Heckel, Armin
- van Meel, Jacques
- Rieder, Conly L
- Peters, Jan-Michael
Producer: 20030619
In:
The Journal of cell biology vol. 161
Availability: No items available.
|
|
1545.
|
|
|
1546.
|
|
|
1547.
|
|
|
1548.
|
|
|
1549.
|
Aurora C is directly associated with Survivin and required for cytokinesis. [electronic resource] by
- Yan, Xiaomei
- Cao, Lihuan
- Li, Qiang
- Wu, Yanhua
- Zhang, Haoxing
- Saiyin, Hexige
- Liu, Xianghua
- Zhang, Xuqing
- Shi, Qinghua
- Yu, Long
Producer: 20050825
In:
Genes to cells : devoted to molecular & cellular mechanisms vol. 10
Availability: No items available.
|
|
1550.
|
|
|
1551.
|
|
|
1552.
|
|
|
1553.
|
|
|
1554.
|
|
|
1555.
|
|
|
1556.
|
|
|
1557.
|
|
|
1558.
|
|
|
1559.
|
|
|
1560.
|
Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors. [electronic resource] by
- Le Brazidec, Jean-Yves
- Pasis, Angela
- Tam, Betty
- Boykin, Christina
- Wang, Deping
- Marcotte, Douglas J
- Claassen, Gisela
- Chong, Jer-Hong
- Chao, Jianhua
- Fan, Junhua
- Nguyen, Khanh
- Silvian, Laura
- Ling, Leona
- Zhang, Lin
- Choi, Michael
- Teng, Min
- Pathan, Nuzhat
- Zhao, Shuo
- Li, Tony
- Taveras, Art
Producer: 20120925
In:
Bioorganic & medicinal chemistry letters vol. 22
Availability: No items available.
|